Patients with advanced cancer prefer open, effective communication
the ONA take:
A majority of patients with advanced cancer in a Japanese population study preferred that their physicians be realistic about their future and be reassured that painful symptoms would be controlled. The study was published online ahead of print in Cancer.
Additionally, patients who had cancer at certain sites, those who were recently diagnosed, as well as those with children, believed that their physicians should effectively communicate their prospects specific to their individual needs.
Researchers led by Shino Umezawa, MS, RN, of Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences looked at 106 patients with cancer who were informed at least one week prior to cessation of their anti-cancer treatment.
Patients were asked to fill out a survey on how they preferred communication regarding the end of their anticancer treatment and transitioning to palliative care.
The researchers found upon descriptive analysis that patients strongly preferred physicians to listen to their distress and concerns (96%), to assure them that painful symptoms would be controlled (97.1%) and to explain the status of their illness and any symptoms that would likely occur in the future (95.1%).
Upon multiple regression analyses to determine the factors associated with these preferences, the researchers found that telling patients to prepare mentally and informing them of their life expectancy was associated with cancer site, sustaining hope was associated with cancer site and children, and empathic paternalism was associated with duration since cancer diagnosis.
A majority of patients with advanced cancer preferred that their physicians be realistic about their future.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|